Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM
· Real-Time Price · USD
3.25
-0.10 (-2.99%)
At close: Aug 15, 2025, 1:28 PM
-2.99% (1D)
| Bid | 3.25 |
| Market Cap | 2.32M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -25.33M |
| EPS (ttm) | 41.76 |
| PE Ratio (ttm) | 0.08 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 3.31 |
| Volume | 93,055 |
| Avg. Volume (20D) | 1,692,914 |
| Open | 3.29 |
| Previous Close | 3.35 |
| Day's Range | 3.08 - 3.37 |
| 52-Week Range | 2.36 - 334.80 |
| Beta | 0.22 |
2 weeks ago
-6.85%
PBM stock has given up its prior gain. Psyence Bio...
Unlock content with
Pro Subscription
2 weeks ago
-6.85%
Psyence Biomedical shares are trading higher after the company announced it, along with PsyLabs, achieved a breakthrough in GMP-aligned high-purity ibogaine production.
1 month ago · newsfilecorp.com
Psyence BioMed Chief of Global Impact to Speak at Psychedelic Science 2025Investors, Entrepreneurs, and Industry Experts to Convene at the Premier Psychedelic Science Business Forum hosted by Multidisciplinary Association for Psychedelic Studies (MAPS) Denver, Colorado--(Ne...
